175 related articles for article (PubMed ID: 3704554)
21. [Neuropathy associated with dysglobulinemia and monoclonal gammopathy].
Saito T
Nihon Rinsho; 1994 Nov; 52(11):2976-83. PubMed ID: 7996697
[TBL] [Abstract][Full Text] [Related]
22. The Immunotyping Distribution of Serum Monoclonal Paraprotein and Environmental Impact on Multiple Myeloma (MM) and Monoclonal Gammopathy of Uncertain Significance (MGUS) in Taiwan: A Medical Center-Based Experience.
Chang CC; Su MJ; Lee SJ; Tsai YH; Kuo LY; Lin IH; Huang HL; Yen TH; Chu FY
Asian Pac J Cancer Prev; 2016; 17(1):395-9. PubMed ID: 26838245
[TBL] [Abstract][Full Text] [Related]
23. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS.
Suarez GA; Kelly JJ
Neurology; 1993 Jul; 43(7):1304-8. PubMed ID: 8327128
[TBL] [Abstract][Full Text] [Related]
24. [A case of severe chronic inflammatory demyelinating polyradiculoneuropathy with monoclonal gammopathy of undetermined significance with alternating immunoglobulin class to IgM from IgA].
Hayashi S; Nagamine S; Makioka K; Kusunoki S; Okamoto K
Rinsho Shinkeigaku; 2016 Sep; 56(9):593-9. PubMed ID: 27580763
[TBL] [Abstract][Full Text] [Related]
25. Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?
Gobbi PG; Baldini L; Broglia C; Goldaniga M; Comelli M; Morel P; Morra E; Cortelazzo S; Bettini R; Merlini G
Clin Cancer Res; 2005 Mar; 11(5):1786-90. PubMed ID: 15756000
[TBL] [Abstract][Full Text] [Related]
26. Incidence of antiphospholipid antibodies in patients with monoclonal gammopathy of undetermined significance.
Stern JJ; Ng RH; Triplett DA; McIntyre JA
Am J Clin Pathol; 1994 Apr; 101(4):471-4. PubMed ID: 8160639
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal gammopathy: natural history studied with a retrospective approach.
Steingrimsdottir H; Haraldsdottir V; Olafsson I; Gudnason V; Ogmundsdottir HM
Haematologica; 2007 Aug; 92(8):1131-4. PubMed ID: 17650445
[TBL] [Abstract][Full Text] [Related]
28. [Epidemiology of monoclonal gammopathy in a general hospital and a university internal medicine department].
Decaux O; Rodon P; Ruelland A; Estepa L; Leblay R; Grosbois B
Rev Med Interne; 2007 Oct; 28(10):670-6. PubMed ID: 17566610
[TBL] [Abstract][Full Text] [Related]
29. Suppression of polyclonal immunoglobulin production by M-proteins shows isotype specificity.
Wang L; Young DC
Ann Clin Lab Sci; 2001 Jul; 31(3):274-8. PubMed ID: 11508831
[TBL] [Abstract][Full Text] [Related]
30. Serum and urine monoclonal immunoglobulins in malignant non-Hodgkin's lymphoma.
Pascali E; Pezzoli A
Acta Haematol; 1986; 75(4):193-8. PubMed ID: 3096049
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal gammopathy related to Sjögren syndrome: a key marker of disease prognosis and outcomes.
Brito-Zerón P; Retamozo S; Gandía M; Akasbi M; Pérez-De-Lis M; Diaz-Lagares C; Bosch X; Bové A; Pérez-Alvarez R; Soto-Cárdenas MJ; Sisó A; Ramos-Casals M
J Autoimmun; 2012 Aug; 39(1-2):43-8. PubMed ID: 22297146
[TBL] [Abstract][Full Text] [Related]
32. Increased frequency of monoclonal gammopathy of undetermined significance in patients with nonimmune chronic idiopathic neutropenia syndrome.
Papadaki HA; Eliopoulos DG; Ponticoglou C; Eliopoulos GD
Int J Hematol; 2001 Apr; 73(3):339-45. PubMed ID: 11345200
[TBL] [Abstract][Full Text] [Related]
33. Neuropathy associated with monoclonal gammopathies of undetermined significance.
Gosselin S; Kyle RA; Dyck PJ
Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
[TBL] [Abstract][Full Text] [Related]
34. [Serum levels of IgG, IgA, IgM, transferrin and haptoglobin. III. Results obtained with monoclonal immunoglobulins].
Pontet F; Later R; Manceaux JC; Pressac M; Boigné JM
Ann Biol Clin (Paris); 1995; 53(5):283-91. PubMed ID: 7574116
[TBL] [Abstract][Full Text] [Related]
35. [Effects on M-protein on laboratory data].
Fujita K; Sakurabayashi I
Rinsho Byori; 2001 Jul; 49(7):682-5. PubMed ID: 11519131
[TBL] [Abstract][Full Text] [Related]
36. Analysis of paraprotein transport into the saliva by using anti-idiotype antibodies.
Kubagawa H; Bertoli LF; Barton JC; Koopman WJ; Mestecky J; Cooper MD
J Immunol; 1987 Jan; 138(2):435-9. PubMed ID: 3794339
[TBL] [Abstract][Full Text] [Related]
37. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
39. Validation and method comparison of the use of densitometry to quantify monoclonal proteins in canine sera.
Harris AD; Rout E; Avery A; Bolte D; Belling-Kelly E; Moore AR
Vet Clin Pathol; 2019 Oct; 48 Suppl 1():78-87. PubMed ID: 31410878
[TBL] [Abstract][Full Text] [Related]
40. Biclonal gammopathy in multiple myeloma: a case report.
Bakta IM; Sutarka IN
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():544-8. PubMed ID: 10895208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
